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Background: TMEM16A and 16B work as Cl--channel, while 
16F works as phospholipid-scramblase. Function of other 
TMEM16 members is unknown. 
Results: Using TMEM16F-/- cells, TMEM16C, 16D, 16F, 16G 
and 16J were shown to be lipid scramblases.  
Conclusion: Some TMEM16 members are divided into two 
Cl--channels and five lipid-scramblases. 
Significance: Learning biochemical function of TMEM16 
family members is essential to understand their physiological 
role. 
 
Asymmetrical distribution of phospholipids between the 
inner and outer plasma membrane leaflets is disrupted in 
various biological processes. We recently identified 
TMEM16F, an eight-transmembrane protein, as a Ca2- 
dependent phospholipid scramblase that exposes 
phosphatidylserine to the cell surface. In this study, we 
established a mouse lymphocyte cell line with a floxed allele 
in the TMEM16F gene. When TMEM16F was deleted, 
these cells failed to expose PS in response to Ca2+ ionophore, 
but PS-exposure was elicited by Fas ligand treatment. We 
expressed other TMEM16 proteins in the TMEM16F-/- cells, 
and found that not only TMEM16F, but also 16C, 16D, 
16G, and 16J work as lipid scramblases with different 
preference to lipid substrates. On the other hand, a patch- 
clump analysis in 293T cells indicated that TMEM16A and 
16B, but not other family members, acted as Ca2+- 
dependent Cl- channels. These results indicated that among 
10 TMEM16 family members, 7 members could be divided 
into two subfamilies, Ca2+ dependent Cl- channels (16A and 
16B) and Ca2+-dependent lipid scramblases (16C, 16D, 16F, 
16G and 16J).  
     
Phospholipids and glycosphingolipids are distributed 
asymmetrically in plasma membrane leaflets, with 
phosphatidylserine (PS) and phosphatidylethanolamine (PE) in 
the inner leaflet, and phosphatidylcholine (PC), 
galactosylceramide (GalCer) and glucosylceramide (GluCer) 
mainly in the outer leaflet (1,2). The lipid asymmetry is 
disrupted in various processes, including apoptotic cell death 
(3), activated platelets (4), red blood cell aging (5), pyrenocyte 
formation in definitive erythropoiesis (6), fusion of 
macrophages, myocytes, or cytotrophoblasts (7-9), and sperm 
capacitation (10).  
Distribution of lipids in plasma membranes is regulated by 
three types of lipid transporters: flippases, floppases and 
scramblases. Flippases, also called ATP-dependent 
aminophospholipid translocases, transport aminophospholipids 
from the extracellular leaflet to the cytoplasmic side (1,11). 
The type IV-P-type ATPases (P4-ATPase), a subfamily of the 
P-type ATPase multispan transmembrane proteins, are strong 
candidates for flippases (12). Floppases are transporters that 
move a wide range of lipids from the cytosolic to the 
extracellular leaflet in an ATP-dependent manner. The 
ATP-binding cassette (ABC) ATPase, particularly ABCA1, 
has been proposed as a floppase (13), but ABCA1-deficient 
cells exhibit no defects in transbilayer phospholipid movement 
(14) arguing against this role.  
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Once established, the phospholipid distribution between the 
outer and inner leaflets is not easily disrupted; ATP-dependent 
translocase inactivation alone does not appear sufficient to 
cause the rapid PS exposure seen in apoptotic cell death and 
platelet activation. Thus, a phospholipid scramblase that 
bi-directionally and non-specifically transports phospholipids 
in response to Ca2+ has been proposed (15). Using a liposome 
reconstitution system with synthetic phospholipids, Basse et al. 
(16) purified a 37-kDa protein from human erythrocytes, and 
named it phospholipid scramblase (PLSCR). Its cDNA was 
then isolated (17). However, since the Ca2+-induced PS 
exposure is normal in PLSCR1-/- cells (18), PLSCR’s function 
as a phospholipid scramblase has been challenged (15,19).  
By repeatedly selecting cell populations that efficiently 
exposed PS in response to Ca2+ ionophore, we recently 
established a subline of mouse pro B cell line (Ba/F3) that 
constitutively exposes PS (20). The Ba/F3 subline harbours a 
mutated form of TMEM16F protein, a protein carrying eight 
transmembrane regions with cytoplasmic N- and C-termini. 
Ba/F3 cells carrying the mutated form of TMEM16F 
constitutively exposed PS and PE, and internalized PC and SM. 
We thus proposed TMEM16F as a phospholipid scramblase 
(20). Confirming that TMEM16F is a Ca2+-dependent 
phospholipid scramblase, recessive TMEM16F mutations were 
identified in human patients with Scott syndrome (20,21), 
which is known to result from a phospholipid-scrambling 
defect; these patients suffer from impaired blood clotting. 
However, it is not clear if TMEM16F is involved in other 
processes, such as apoptotic cell death or cell fusion. Two of 
the TMEM16 family’s 10 members, TMEM16A and 16B, are 
Ca2+-dependent Cl- channels (22-24); this raises a question of 
whether TMEM16F is likewise a Cl- channel, and whether any 
other TMEM16 family members are phospholipid scramblases.  
In this report, we established an immortalized fetal 
thymocyte (IFET) cell line from fetal thymus of mice carrying 
a floxed TMEM16F allele. IFETs express TMEM16F, 16H, 
and 16K, and expose PS in response to a Ca2+ ionophore. 
Deleting TMEM16F in the IFETs completely abolished their 
ability to expose PS in response to Ca2+-ionophore. On the 
other hand, Fas ligand (FasL) treatment efficiently induced PS 
exposure in the TMEM16F- deficient cells. In the presence of 
TMEM16C, 16D, 16F, 16G, and 16J, TMEM16F-/- IFETs 
responded to Ca2+ ionophore by scrambling phospholipids and 
galactosylceramide, while other family members did not. On 
the other hands, the two family members, TMEM16A and 16B, 
but not others showed the Ca2+-dependent Cl- channel activity. 
These results, together with their tissue-specific expression, 
suggest that the TMEM16 family members have distinct 
functions in lipid scrambling and Cl--channel functions in 
various biological processes. 
 
EXPERIMENTAL PROCEDURES 
Materials and Cell Lines---Leucine-zipper-tagged human 
FasL was produced in COS7 cells as described (25). One unit 
of FasL is defined as the activity that kills 1.0 x 105 mouse 
WR19L cell expressing Fas (W3 cells) in 4 h. A caspase 
inhibitor, Q-VD-OPh (quinolyl-valyl-O- methylaspartyl- 
[-2,6-difluorophenoxy]-methyl ketone) was purchased from 
R&D systems (Minneapolis, MN). IFETs were maintained in 
RPMI medium containing 10% FCS (Nichirei Bioscience, 
Tokyo, Japan) and 50 µM β-mercaptoethanol. HEK293T and 
Plat-E cells (26) were cultured in DMEM containing 10% 
FCS. 
cDNA Cloning---Mouse TMEM16F cDNA (NCBI: 
NM_175344) was described (20). Mouse cDNAs for 
TMEM16A (GenBank: BC062959.1), 16B (GenBank: 
BC033409.1), and 16G (GenBank: BC116706.1) were from 
DNAFORM (Yokohama, Japan). Mouse cDNAs for 
TMEM16C (NCBI: NM_ 001128103.1), 16D (Ensemble: 
ENSMUST 00000070175), and 16K (NCBI: NM_133979.2) 
were cloned from brain tissue by RT-PCR, while cDNAs for 
TMEM16E (NCBI: NM_177694.5), 16H (NCBI: 
NM_001164679.1), and 16J (NCBI: NM_178381.3) were 
isolated from the skeletal muscle, thymus, and stomach, 
respectively. All cDNAs were verified by sequencing. The 
following primers were used to isolate TMEM16 cDNAs (the 





























Since the native mouse cDNAs for TMEM16C, 16D, and 
16E produced a low level of proteins in mammalian cells, 
sequences with enhanced mRNA stability and 
translational efficiency were custom ordered from 
GENEART (Regensburg, Germany)(Fig. S1-S3) .  
Establishment of TMEM16F-/- IFET Cell Line---- 
TMEM16F conditionally targeted mice were generated by 
UNITECH (Chiba, Japan) as a custom order. In brief, a 
neo-loxP cassette carrying the PGK promoter-driven neo gene 
and flanked by FRT sequences was inserted into intron 3 of the 
TMEM16F gene (Fig. 1A). A 1.0 kb-DNA fragment containing 
exon 2 was replaced with a fragment carrying the 
corresponding sequence and a loxP sequence. The diphtheria 
toxin A-fragment (DT-A) driven by the thymidine kinase (tk) 
promoter, was inserted at 5’ end of the vector. Mouse Bruce-4 
ES cells were transfected with the targeting vector by 
electroporation, and G418-resistant clones were screened for 
homologous recombination by PCR. Positive clones were 
injected into blastocysts to generate TMEM16F+/NeoFRT mice. 
The TMEM16F+/NeoFRT mice were crossed with CAG-FLPe 
transgenic mice to remove the Neo cassette (27). Offspring 
were backcrossed to wild-type C57BL/6 mice to remove the 
CAG-FLPe transgene, generating TMEM16F+/flox mice. Mice 
were housed in a specific pathogen-free facility at Kyoto 
University, and all animal experiments were carried out in 
accordance with protocols approved by Kyoto University. 
IFET cell lines were established as described (28). In brief, 
TMEM16F+/flox mice were intercrossed, and fetal thymocytes 
were obtained at embryonic day 14.5. Thymocytes were 
cultured in DMEM containing 10% FCS, 1 x non-essential 
amino acids, 10 mM Hepes-NaOH buffer (pH 7.4), and 50 µM 
β-mercaptoethanol. Retroviruses carrying genes for H-rasV12 
and c-myc were produced in Plat-E cells with pCX4 vector 
(29), concentrated by centrifugation, and attached to 
RetroNectin-coated plates (Takara Bio, Kyoto, Japan). 
Thymocytes were attached to the retrovirus-coated plate by 
centrifugation at 400 x g for 5 min, and cultured in medium 
containing 5 ng/ml mouse IL-7 (PeproTech, Rocky Hill, NJ) 
(30). The resultant IFETs were infected with 1 x 105 pfu/ml 
Adeno-Cre (Takara Bio) and cloned by limited dilution. Clones 
carrying the TMEM16F-/- allele were selected by PCR with 
following primers: wild-type specific sense primer, 
CTCCAGAGTTTGTAAGTAACACAT, mutant specific sense 
primer, CAGTCATCGATGAATTCATAACTT, and common 
anti-sense primer, AAGACTGATTTCCAAGG TTATCGAA.  
Transformation of TMEM16F-/- IFETs---Mouse TMEM16 
cDNAs were inserted into pMXs puro c-FLAG (20) to express 
proteins tagged with FLAG at the C-terminus. Retrovirus was 
produced in Plat-E cells, and used to infect TMEM16F-/- IFETs. 
Stable transformants were selected in medium containing 2 
µg/ml puromycin. Mouse Fas cDNA (GenBank: NM_007987) 
was introduced into IFETs by retrovirus-mediated 
transformation, and its expression was confirmed by flow 
cytometry with an anti-Fas mAb (Jo2) (MBL, Nagoya, Japan).  
Real-time PCR---Total RNA was reverse-transcribed using 
Superscript III reverse-transcriptase (Invitrogen, Carlsbad, CA) 
or a High Capacity RNA-to-cDNA™ kit (Applied Biosystems, 
Foster City, CA). Aliquots of the products were amplified in a 
reaction mixture containing LightCycler®480 SYBR Green I 
Master (Roche Diagnostics, Basel, Switzerland). Primers used 






















5’-TTTGATGTCACGCACGATTTCC. The mRNA was 
quantified at the point where Light Cycler System detected the 
upstroke of the exponential phase of PCR accumulation with 
the respective linearized plasmid DNA as reference.  
Western Blotting---Cells were lysed in RIPA buffer [50 mM 
Hepes-NaOH buffer (pH 8.0) containing 1% NP-40, 0.1% SDS, 
0.5% sodium deoxycholate, 150 mM NaCl, and protease 
inhibitor cocktail (Complete Mini, Roche Diagnostics)]. After 
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removing debris, cell lysates were mixed with 5 x SDS sample 
buffer [200 mM Tris-HCl (pH 6.8), 10% SDS, 25% glycerol, 
5% β-mercaptoethanol, and 0.05% Bromophenolblue], 
incubated at room temperature for 30 min, and separated by 
10% SDS-PAGE (Bio Craft, Tokyo, Japan). After transferring 
proteins to a PVDF membrane (Millipore, Billerica, MA), 
membranes were probed with HRP-conjugated mouse 
anti-FLAG M2 (Sigma-Aldrich, St. Louis, MO), and 
peroxidase activity was detected using a Western 
Lightning®-ECL system (PerkinElmer, Waltham, MA).  
To prepare rabbit antibody against mouse TMEM16F, the 
N-terminal region of mouse TMEM16F (amino acids from 
1-289) was fused to glutathione-S-transferase (GST) in a 
pGEX-5X-1 vector (GE Healthcare, Buckinghamshire, 
England). The recombinant protein was produced in E. coli, 
purified with Glutathione-Sepharose, and used to immunize 
rabbits at Takara Bio as a custom order. Western blotting with 
the rabbit anti-TMEM16F and HRP-labeled goat anti-rabbit Ig 
(Dako, Copenhagen, Denmark) was carried out as described 
above using Immunoreaction Enhancer Solution (Can Get 
Signal○R, Toyobo Life Science, Tokyo, Japan).  
Analysis of PS Exposure---The Ca2+-induced PS exposure 
were examined as described (20). In brief, 5 x 105 cells were 
stimulated at 20°C with 3.0 µM A23187 in 500 µl of 10 mM 
Hepes-NaOH buffer (pH 7.4) containing 140 mM NaCl, 2.5 
mM CaCl2 and 5 µg/ml Propidium Iodide (PI), and 
1000-fold-diluted Cy5-labeled Annexin V (Bio Vision, 
Milpitas, CA), and applied to the injection chamber of a 
FACSAria (BD Bioscience, Franklin Lakes, NJ) set at 20°C.  
Internalization of NBD-PC and NBD-GalCer---Cells (106) 
were stimulated at 15°C with 250 nM A23187 in 1 ml Hank’s 
Balanced Salt Solution (HBSS)(Gibco, Billings, MT) 
containing 1 mM CaCl2, with a fluorescent probe, 100 nM 
1-oleoyl-2-{6-[(7-nitro-2-1,3- benzoxadiazol-4-yl)amino] 
hexanoyl}-sn-glycero-3-phosphocholine (NBD-PC)(Avanti 
Polar Lipids, Alabaster, AL), or 250 nM N-[6-[(7-nitro- 
2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-galactosyl-β1-1'
- sphingosine (C6-NBD galactosyl ceramide or NBD-GalCer) 
(Avanti Polar Lipids). Aliquots (150 µl) were mixed with 150 
µl HBSS containing 5 mg/ml fatty-acid free BSA 
(Sigma-Aldrich) and 500 nM Sytoxblue (Molecular Probes, 
Eugene, OR), and analyzed by FACSAria.  
Induction of Apoptosis---Apoptosis was induced with FasL 
as described (25). In brief, IFETs expressing mouse Fas were 
treated with 60 units/ml FasL at 37°C for 2 h, and PS exposure 
was determined by flow cytometry with Cy5- Annexin V. To 
detect activated caspase 3, cells were fixed at 37°C for 10 min 
in PBS containing 1% paraformaldehyde, permeabilized with 
90% methanol at -20°C, and stained with rabbit mAb against 
active caspase 3 (Cell Signaling, Danvers, MA). Cells were 
then incubated with Alexa 488-labeled goat anti-rabbit IgG 
(Invitrogen), and analyzed by FACSAria. 
Electrophysiology---TMEM16 sequences, FLAG-tagged at 
C-terminus, were inserted into pEF-BOS-EX (31). HEK293T 
cells (2.5 x 105) were co-transfected with 1.0 µg of TMEM16 
expression vector and 0.1 µg of pMAX-EGFP (Lonza Group, 
Basel, Switzerland) using FuGENE6 (Promega, Madison, WI). 
At 24 h after transfection, cells were re-seeded on glass 
coverslips coated with fibronectin (Sigma-Aldrich). Within 24 
h after re-seeding, whole-cell recordings of cells expressing 
EGFP were performed using a patch-clamp amplifier 
(Axopatch 200B, Molecular Devices, Sunnyvale, CA) as 
described (23,32). The extracellular solution contained 140 
mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 30 mM 
glucose, and 10 mM Hepes-NaOH (pH 7.4). The intracellular 
solution contained 140 mM NaCl, 1.12 mM EGTA, 1 mM 
CaCl2, 30 mM glucose, and 10 mM Hepes-NaOH (pH7.4). The 
free Ca2+ concentration (500 nM) was calculated with 




Establishment of TMEM16F-/- Fetal Thymocyte Cell Lines 
---Ca2+-dependent PS exposure is reduced by knocking down 
TMEM16F mRNA and accelerated by TMEM16F 
overexpression, suggesting that TMEM16F is a phospholipid 
scramblase (20). To demonstrate TMEM16F’s involvement in 
Ca2+-dependent phospholipid scrambling and to determine 
whether TMEM16F plays a role in exposing PS to the cell 
surface during apoptotic cell death, we established from fetal 
thymus tissue a TMEM16F-deficient mouse cell line that 
expresses a small number of TMEM16 family members, 
including TMEM16F (see below). 
A targeting vector in which exon 2 of TMEM16F gene was 
flanked by loxP sequences was used to replace the TMEM16F 
allele in a mouse embryonic stem cell (ES) line from a 
C57BL/6 background (Fig. 1A). Mice carrying the floxed 
allele were generated from the ES clone, and intercrossed. 
Embryos were genotyped at embryonic day 14.5, and fetal 
TMEM16Fflox/flox thymus cells were infected with a retrovirus 
carrying H-rasV12 and c-myc to establish IFET cell lines. Flow 
cytometry analysis showed that IFETs expressed Thy-1 weakly 
and CD44 strongly, but did not express CD4 or CD8; this 
indicated that they were derived from a T-cell lineage at an 
early developmental stage. A real-time RT-PCR analysis 
showed that IFETs expressed TMEM16F, 16H and 16K (Fig. 
1B). Next, IFETs were infected with adenovirus carrying the 
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CRE recombinase gene, and cells missing exon 2 of the 
TMEM16F gene were cloned (Fig. 1C). Removing exon 2 
causes a frame-shift and truncates TMEM16F protein at the 
N-terminal region. Accordingly, Western blotting with an 
anti-TMEM16F antibody showed broad bands around 120 kDa 
in TMEM16Fflox/flox but not TMEM16F-/- IFETs (Fig. 1D). An 
apparent Mr of TMEM16F detected by SDS-PAGE is slightly 
larger than the expected Mr for TMEM16F (106 kDa), which 
may be explained by glycosylation, since mouse TMEM16F 
carry 6 putative N-glycosylation sites (Asn-X-Ser/Thr).  
Requirement of TMEM16F for Ca2+-Induced, but not 
Apoptotic PS-Exposure---TMEM16Fflox/flox IFETs treated at 
20°C with a Ca2+ ionophore A23187 quickly exposed PS (Fig. 
2A); however, this exposure was completely absent in 
TMEM16-/- IFETs. Similarly, the treatment of TMEM16Fflox/flox 
but not TMEM16F-/- IFETs with A23187 caused rapid 
PE-exposure, detected by binding of RO-peptide (20) (data not 
shown). We then examined the role of TMEM16F in lipid 
internalization, and found that TMEM16Fflox/flox but not 
TMEM16-/- IFETs internalized NBD-PC and NBD-GalCer 
upon Ca2+-ionophore treatment (Fig. 2B and 2C). These results 
indicated that TMEM16F is responsible for Ca2+-dependent 
lipid scrambling in IFETs.  
In agreement with previous report showing that Fas is not 
expressed in T cells at early developmental stages (33), IFETs 
do not express Fas (Fig. 2D). When IFETs were transformed 
with mouse Fas, FasL efficiently activated caspase 3 (Fig. 2E) 
and the cells quickly responded by exposing PS (Fig. 2F). A 
TMEM16F-null mutation did not affect either FasL-induced PS 
exposure or caspase activation (Fig. 2E and 2F). In cells 
undergoing apoptosis, cell size decreases and cellular 
granularity increases (34). Treating the TMEM16Fflox/flox and 
TMEM16F-/- IFETs with FasL decreased the cell size 
(forward-scattered light, FSC) and increased the cellular 
granularity (side-scattered light, SSC) to the same extent (Fig. 
2G). Therefore, we concluded that caspase-dependent 
apoptotic PS exposure and cell shrinkage take place 
independently of TMEM16F.  
TMEM16 Family Members’ Abilities to Expose PS---The 
ten TMEM16 family members have similar topologies, and 
20-60% amino acid sequence identity (35,36). To examine 
TMEM16 family members’ ability to scramble phospholipids, 
we transformed TMEM16F-/- IFETs, in which the 
Ca2+-dependent lipid scramblase activity is completely lost, 
with mouse retroviral vectors carrying FLAG-tagged 
TMEM16 family members. Since the expression plasmids for 
TMEM16C, 16D, and 16E with their endogenous sequences 
produced very low protein levels in IFETs, their sequences 
were modified to optimize the mRNA stability and translation 
efficiency. Western blots with an anti-FLAG mAb detected a 
specific band for each TMEM16 family member (Fig. 3A). 
Except for TMEM16K, their apparent Mr, detected by 
SDS-PAGE, is larger than the calculated Mr, which may be 
explained by glycosylation because these members carry 1-6 
N-glycosylation sites. On the other hand, the apparent Mr (65 
kDa) of TMEM16K, that does not have a putative 
N-glycosylation site, was significantly smaller than its 
estimated Mr (76 kDa). Some membrane proteins are known to 
behave anomalously in SDS-PAGE (37), and TMEM16K may 
belong to the group of this category. The Western blots also 
showed that most of the TMEM16 family members were 
expressed at similar levels, except that the TMEM16E level 
was 3-5 times lower, and TMEM16K level 5-10 times higher 
than those of other family members (Fig. 3A). As expected, 
Ca2+ ionophore treatment efficiently induced TMEM16F-/- 
IFET transformants expressing TMEM16F to expose PS (Fig. 
3B). The TMEM16D- as well as TMEM16G and 16J- 
transformants also exposed PS upon Ca2+-treatment, although 
the ability of TMEM16G, or 16J to enhance the PS exposure 
was weaker than that of TMEM16F and 16D. On the other 
hand, no or little PS-exposing activity was detected with 
TMEM16A, 16B, 16C, 16E, 16H and 16K. Similarly, 
TMEM16F-/- IFETs lost the ability to internalize NBD-PS, and 
this activity was rescued strongly by transforming the cells 
with TMEM16D, 16F, and 16J, and weakly by 16G. While, 
IFETs transformants expressing TMEM16C and 16E did not 
internalize NBD-PS (data not shown).  
TMEM16 Family Members’ Abilities to Scramble Lipids 
---TMEM16F scrambled not only PS and PE, but also other 
lipids (Fig. 2). To examine the lipid scramblase activity of 
other TMEM16 family members, TMEM16F-/- IFETs 
expressing TMEM16 family members were incubated with a 
fluorescent probe, NBD-PC or NBD-GalCer. As shown in Fig. 
4A, the TMEM16F-/- IFETs expressing TMEM16D 
constitutively, or without A23187-treatment, internalized 
NBD-PC, and this internalization was strongly enhanced by 
the A23187 treatment. The A23187- induced NBD-PC uptake 
with the TMEM16D transformants was stronger than that 
observed with the 16F-transformants. Pre-treatment of 
TMEM16D-transformants with BAPTA-AM, a cell-permeable 
Ca2+ chelator, reduced the NBD-PC uptake observed without 
Ca2+-ionophore (Fig. 4B), suggesting that the endogenous 
cellular level of Ca2+ is sufficient to activate the scrambling 
activity of TMEM16D. As with PS exposure, the A23187- 
treatment did not induce NBD-PC uptake in IFETs expressing 
TMEM16A, 16B, 16E, 16H, or 16K (Fig. 4A). However, cells 
expressing TMEM16C, 16G, or 16J did internalize NBD-PC 
when treated with Ca2+ ionophore.  
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A similar result was obtained using NBD-GalCer as a 
substrate. When treated with A23187, TMEM16F-/- 
transformants expressing TMEM16F incorporated NBD- 
GalCer, but those expressing TMEM16A, 16B, 16E, 16H, or 
16K did not (Fig. 4C). Cells expressing TMEM16D 
constitutively incorporated NBD-GalCer, and this uptake was 
enhanced by A23187 treatment. The cells expressing 
TMEM16C, 16G, or 16J also internalized NBD-GalCer, 
although TMEM16C’s ability to internalize NBD-GalCer was 
weaker compared with others. These results suggested that 
TMEM16C, 16D, 16F, 16G and 16J scramble various 
phospholipids and glycosphingolipids with some different 
substrate preference.  
Chloride Channel Activity of TMEM16 Family 
Members---TMEM16A and 16B are Ca2+-dependent Cl- 
channels (22-24). To determine whether there are any other 
TMEM16 family Cl- channels, and whether the scramblase 
activity of TMEM16 family members depends on Cl--channel 
activity, human 293T cells were co-transfected with the 
TMEM16 expression plasmid and a vector expressing GFP 
(Fig. 5A). The Ca2+-dependent chloride channel activity in 
GFP-positive cells was then determined by whole-cell patch 
clamp analysis (23). We chose 293T cell line as host cells 
because it has little Ca2+-dependent Cl--channel activity (Fig. 
5B) and was used successfully to show that TMEM16A and 
16B act as Cl- channels (22-24).   
In the patch-clamp analysis, increasing the intracellular free 
Ca2+ in the pipette solution to 500 nM yielded large outward 
rectifying currents in cells expressing TMEM16A or 16B (Fig. 
5B and 5C). In contrast, other TMEM16 family members 
induced little if any Ca2+-dependent current in 293T cells, and 
the effect of increasing the pipette solution Ca2+ concentration 
from 500 nM to 5 µM was negligible (data not shown). 
Therefore, we concluded that within the TMEM16 family, 
only TMEM16A and 16B act as Ca2+-dependent Cl- channels, 
and that the phospholipid scrambling activity of TMEM16C, 
16D, 16F, 16G, and 16J is independent of Cl--channel activity. 
Expression of TMEM16 Family Members in Mouse Tissues 
---Real-time PCR analysis of TMEM16 mRNA in various 
mouse tissues showed that each tissue expressed only a limited 
number of TMEM16 family members (Fig. 6). Of the two Cl- 
channels of TMEM16 family, TMEM16A and 16B, we found 
that TMEM16B was strongly expressed in brain and eye 
tissues, but weakly expressed or absent in tissues where 
TMEM16A was strongly expressed, such as the pancreas, liver, 
salivary glands, stomach, lung, skin, and mammary glands. Of 
the 5 lipid scramblases of TMEM16 family, 16C, 16D, 16F, 
16G and 16J, TMEM16F was ubiquitously expressed in 
various tissues. Whereas, other scramblases were present only 
in a few tissues: TMEM16C and 16J were strongly expressed 
in the brain and skin, respectively, while 16D was found at a 
low level in a few tissues such as the brain, ovary, heart, and 
eyes, and 16G and 16J were found in the stomach and 
intestines. Of the TMEM16 proteins that did not show 
scramblase or Cl--channel activity, 16H and 16K were 
expressed ubiquitously in various tissues, while 16E was 
expressed only in the muscle and skin.  
 
Discussion 
Various biological processes require that PS, normally 
located in the inner plasma membrane leaflets, be exposed to 
the outer leaflet in response to Ca2+ (11,15). Previously, our 
search for a Ca2+-activated phospholipid scramblase identified 
TMEM16F, a protein with eight transmembrane regions (20). 
Here we showed that TMEM16F-deficient cells failed to 
expose PS in response to Ca2+. However, FasL-induced cell 
shrinkage, PS exposure, and caspase activation, were all 
comparable between the wild-type and TMEM16F-/- IFET 
cells; this agrees with our previous results that a constitutively 
active form of TMEM16F has no effect on FasL-induced 
apoptotic cell death (38). This is also consistent with the report 
by Williamson et al. (39) that an EBV-transformed cell line 
established from a Scott patient exposed PS in response to 
apoptotic signals but not in response to Ca2+, and it supports 
the proposal that there are two distinct pathways for PS 
exposure in platelets (40). On the other hand, Martins et al. 
(41) recently suggested that TMEM16F is involved in 
apoptotic cell death, based on PS-exposure and cell shrinkage 
in a study using the siRNA and the TMEM16F inhibitor 
CaCCinh-AO1. Whether these apparently different results are 
due to different methods and cell lines remains to be clarified. 
IFETs expressed TMEM16F, 16H and 16K; of these only 
16F acted as a Ca2+-dependent phospholipid scramblase. This 
result was consistent with our finding that TMEM16F-deficient 
IFETs failed to expose PS when treated with Ca2+ ionophore. 
However, our results are inconsistent with a previously 
reported finding that Ca2+ is required to expose PS during 
apoptotic cell death (42). Preliminary analysis with several cell 
lines suggests that the Ca2+ requirement for apoptotic PS 
exposure depends on cell lines; Ca2+ is required for apoptotic 
PS exposure in mouse T cell lymphoma WR19L, but not in 
Ba/F3 and IFETs (J. S. and S. N., unpublished results). How 
this is regulated may become clear only when the scramblase 
responsible for apoptotic PS exposure is identified.  
There are ten TMEM16 family members, which all have 8 
transmembrane regions with cytosolic N- and C-termini 
(35,36). When TMEM16A and 16B were found to be Cl- 
channels, it was thought that other family members would 
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have the same function. This family was therefore designated 
as the “anoctamin” or “ano” (anion and octa) family (24,35,43). 
However, except for one report of Cl--channel activity in 
TMEM16F, 16G and 16K (44), Cl--channel activity has only 
been detected for TMEM16A and 16B [(45) and this report]. 
Duran et al. (2012) suggested that other family members might 
not act as Cl- channels because of their intracellular 
localization. Here, we showed that five TMEM16 family 
members, 16C, 16D, 16F, 16G, and 16J can scramble 
phospholipids and/or glycosphigolipids, with different 
preference to lipids. TMEM16G and 16F are present in the 
plasma membrane (20)(K.I. and S.N., unpublished results), and 
it is likely that other TMEM16- family scramblases are also 
located in the plasma membrane. On the other hand, TMEM16 
family members (16E, 16H, and 16K) that have neither 
scramblase activity nor Cl- channel activity may not be present 
in the plasma membrane. In fact, immunohistochemical 
analysis with hamster mAb against TMEM16E and 16K 
showed that they are localized in endoplasmic reticulum or 
Golgi apparatus (S. Gyobu, K.I., J.S., and S.N., unpublished 
results). We found here that TMEM16C scrambles PC and 
GalCer, but not PS, suggesting a substrate specificity for 
TMEM16 family members. Identification of the active site, 
and its mutational analysis will be necessary to understand 
how this specificity is generated. 
The ABC transporters and P-type ATPases encompass 
transporters that regulate lipid efflux and influx, respectively, 
in an ATP-dependent manner (46,47). These families include 
channels for cationic and anionic ions. We showed here that 
TMEM16 family members, which are activated by Ca2+, also 
can be divided into lipid scramblases (16C, 16D, 16F, 16G and 
16J) and Cl- channels (16A and 16B). The amino acid 
sequence in the first cytoplasmic region is well-conserved 
among TMEM16 family members, and suggests its common 
role such as Ca2+-signaling (38,48). The third extracellular 
loop, which forms a “pore region” and plays an important role 
in the Cl- channel activity (24), is also well conserved among 
the family members. Whether this region is involved in the 
lipid scrambling remains to be determined. In any case, it will 
be an interesting challenge to determine how some TMEM16 
members work as Cl--channel, while others work as lipid 
scramblases. 
The amino acid sequences of TMEM16E that showed 
neither scramblase nor Cl--channel activity is 49.2% identical 
with that of TMEM16F; this is higher than the 40.7% identity 
between lipid scramblase TMEM16D and 16F. This, along 
with TMEM16E’s localization to intracellular vesicles (49), 
suggests that it may be a lipid scramblase that works at 
intracellular vesicles. TMEM16E mutations cause human 
diseases GDD (gnathodiaphyseal dysplasia), MMD3 (Miyoshi 
muscular dystrophy 3), and LGMD2L (muscular dystrophy, 
limb-girdle, type 2L) (50,51) in bone and muscle, and 
understanding whether TMEM16E functions as a Cl- channel 
or lipid scramblase will be important to understanding the 
pathology of these diseases. TMEM16H and 16K, that also 
have neither the scramblase nor Cl- channel activity, are 
primordial members of the TMEM16 family, and their 
orthologs can be found in C. elegans and Drosophila. To 
understand how the loss-of function mutations of TMEM16K 
gene causes cerebellar ataxia in humans (52), it will be 
necessary to elucidate the TMEM16K’s biochemical function.  
The PS exposure to the cell surface plays an important role 
not only in apoptotic cell death and of platelet activation, but 
also in cell fusion (8,53), neutrophils turnover (54), and the 
interaction of lymphocytes with antigen-presenting cells 
(55,56). In most of these processes, the PS exposure depends 
on Ca2+, suggesting that a TMEM16 family member is 
involved. However, of the five TMEM family members (16C, 
16D, 16F, 16G and 16J) that can scramble lipids, only 16F is 
expressed in muscle, lymphocytes, and bone marrow. In fact, 
Ehlen et al. recently showed that TMEM16F-/- osteoblasts lost 
the ability to scramble PS, leading to the decreased deposition 
of mineral in the bone tissues (57). It will be interesting to 
examine whether the other tissues such as muscles and 
immune system develop normally in TMEM16F-/- mice, or in 
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FIGURE LEGENDS 
FIGURE 1. Establishment of TMEM16F-/- IFET cell line. A, Schematic representation of wild-type and mutant TMEM16F 
alleles together with the targeting vector. Recognition sites for Eco RI (E), Eco RV (V), Kpn I (K), and Sma I (S) in the flanking 
region of exon 2 (filled box) are indicated. In the target vector, a 1.0-kb DNA fragment carrying exon 2 and its flanking region 
was replaced by a 2.7-kb fragment carrying two loxP sequences (filled arrowhead) and PGK-neo (NeoR) flanked by FRT 
sequences (gray arrowhead). Diphtheria toxin A-fragment (DT-A) driven by the tk promoter was inserted at 5’ site of the vector. 
In NeoFRT allele, TMEM16F chromosomal gene was replaced by the targeting vector. In Floxed allele, the FRT-flanked NeoR 
gene was removed by FLPe recombinase. In deleted allele, the loxP-flanked exon 2 of TMEM16F gene was deleted by Cre 
recombinase. Primers used in Fig. 1C are indicated by arrows. Scale bar, 1.0 kb. B, Real-time PCR analysis for mRNA of 
TMEM16F family members in IFETs. An IFET cell line was established from TMEM16Fflox/flox fetal thymocytes. TMEM16A-16H, 
16J and 16K mRNA in TMEM16Fflox/flox IFETs was quantified by real-time PCR, and expressed relative to β-actin mRNA. The 
experiment was carried out for three times, and the average value was plotted with S.D. (bar). C, Deletion of TMEM16F exon 2 in 
the IFET cell line. TMEM16Fflox/flox IFETs were infected by Cre-bearing adenovirus to establish TMEM16F-/- IFET cells. 
Chromosomal DNA from TMEM16Fflox/flox and TMEM16F-/- IFETs was analyzed by PCR with the primers indicated in Fig. 1A. D, 
Western blots for TMEM16F in TMEM16Fflox/flox and TMEM16F-/- IFETs. Cell lysates (10 µg proteins) were separated by 7.5% 
SDS-PAGE, and blotted with rabbit anti-TMEM16F serum (upper panel) or anti-α-tubulin antibody (lower panel). Molecular 
weight standards (Precision Plus Standard, Bio-Rad) are shown in kDa at left.  
 
FIGURE 2. An indispensable role of TMEM16F for Ca2+-induced but not apoptotic PS exposure. A, Ca2+ ionophore induced 
PS exposure. TMEM16Fflox/flox and TMEM16F-/- IFETs were treated at 20°C with 3.0 µM A23187 in the presence of Cy5-labeled 
Annexin V. Annexin V-binding to the cells was monitored by flow cytometry for 10 min, and expressed in MFI (mean 
fluorescence intensity). B and C, Ca2+ ionophore induced lipid internalization. TMEM16Fflox/flox and TMEM16F-/- IFETs were 
treated at 15°C with 250 nM A23187 in the presence of 100 nM NBD-PC (B) or 250 nM NBD-GalCer (C). Using aliquots of the 
reaction mixture, the BSA-non extractable level of NBD-PC or NBD-GalCer in the SytoxBlue-negative population was 
determined at the indicated time by FACSAria, and expressed in MFI. D, Transformation of IFETs with mouse Fas. 
TMEM16Fflox/flox and TMEM16F-/- IFETs were infected with a retrovirus carrying mouse Fas, and were stained with a PE-labeled 
hamster mAb against mouse Fas (green). The staining profile of parental cells is also shown (red). E-G, FasL-induced apoptosis. 
Fas-expressing TMEM16Fflox/flox and TMEM16F-/- IFETs were treated at 37°C for 2 h with 60 units/ml FasL in the absence or 
presence of 50 µM Q-VD-OPh. In E, the cells were permeabilized with 90% methanol, and stained with rabbit anti-active caspase 
3 followed by incubation with Alexa 488-labeled goat anti-rabbit IgG. In F, cells were stained with Cy5-labeled Annexin V and PI 
and analyzed by FACSAria. In G, cells were analyzed by FACSAria before and after FasL treatment; the FSC and SSC profiles 
are shown. 
 
FIGURE 3. Ca2+-dependent PS exposure by TMEM16 family members. The ten TMEM16 family members were FLAG- 
tagged at C-terminus and introduced into TMEM16F-/- IFETs to establish stable transformants. A, Western blotting. TMEM16 
protein expression in each transformant was analyzed by Western blotting with an anti-FLAG mAb. Note that the amount of 
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TMEM16K lysate protein analyzed was one-eighth that of the others. B, Ca2+-induced PS exposure by TMEM16 family members. 
TMEM16F-/- IFETs transformed with the indicated TMEM16 family member were stimulated with 3.0 µM A23187. Annexin V 
binding was monitored with a FACSAria at 20°C for 2 min, and expressed in MFI. The experiments were carried out for three 
times, and the average values were plotted with S.D. (bars). 
 
FIGURE 4. Ca2+-dependent internalization of NBD-PC and NBD-GalCer by TMEM16 family members. A and C, The 
ability of TMEM16 family members to internalize NBD-PC and NBD-GalCer. TMEM16F-/- IFETs transformed with the indicated 
TMEM16 family member were treated at 15°C with (+) or without (-) 250 nM A23187 in the presence of 100 nM NBD-PC for 4 
min (A) or 250 nM NBD-GalCer for 5 min (C), and the internalized, or BSA-non extractable NBD-PC or NBD-GelCer, was 
quantified by FACSAria, and expressed in MFI. B, Requirement of Ca2+ for the constitutive internalization of NBD-PC by 
TMEM16D. The TMEM16D transformants of TMEM16F-/- IFETs were treated with 40 µM BAPTA-AM for 30 min in Ca2+-free 
RPMI, and incubated at 15°C for 8 min in HBSS containing 1 mM CaCl2 and 100 nM NBD-PC. The internalized NBD-PC was 
determined as above, and expressed as percentage of the internalized NBD-PC obtained without BAPTA-AM treatment. All 
experiments in Fig. 4A, 4B, and 4C were carried out for three times, and the average values were plotted with S.D. (bars). 
 
FIGURE 5. Ca2+-dependent Cl--channel activity of TMEM16 family members. A, Expression of TMEM16 family members in 
HEK293T cells. HEK293T cells were transfected with a pEF-BOS-EX vector carrying cDNA for the flag-tagged TMEM16 
family member. Two days later, the expression level of each TMEM16 member was analyzed by Western blotting with anti-Flag 
and anti-α-tubulin mAbs. Note that the amount of TMEM16K lysate protein analyzed was one-eighth that of the others. B, Ca2+ 
ionophore-induced TMEM16A and 16B Cl--channel activity. HEK293T cells were co-transfected with a pEF-BOS-EX vector 
carrying TMEM16A or 16B cDNA, and pMAX-EGFP. Two days later, the Cl--channel activity of EGFP-positive cells was 
examined by electrophysiology. The pipette (intracellular) solution contained 500 nM free Ca2+. Representative whole-cell 
membrane currents elicited at -120 to +120 mV in 10 mV-steps are shown for vector-, TMEM16A-, and 16B-transfected cells. 
The holding membrane potential was maintained at 0 mV. C, Outward rectification of the Cl- current by TMEM16 family 
members. HEK293T cells were co-transfected with pMAX-EGFP and pEF-BOS-EX vector for the indicated TMEM16 family 
member, and electrophysiology was carried out as described above. Membrane currents were measured at the indicated voltage 
pulses (Vm). Experiments were independently done 3-5 times, and the average values were plotted against the applied membrane 
potential with S.D. (bars).  
 
FIGURE 6. Real-time PCR analysis for TMEM16 family member mRNA in mouse tissues. RNA was prepared from the 
indicated mouse tissues, and mRNA level quantified by real-time PCR were expressed relative to β-actin mRNA for each 
TMEM16 family member.  
 
 
 
 
 






